The  ||| S:0 E:4 ||| DT
squamous  ||| S:4 E:13 ||| JJ
cell  ||| S:13 E:18 ||| NN
carcinoma  ||| S:18 E:28 ||| NN
at  ||| S:28 E:31 ||| IN
the  ||| S:31 E:35 ||| DT
level  ||| S:35 E:41 ||| NN
of  ||| S:41 E:44 ||| IN
the  ||| S:44 E:48 ||| DT
cephalic  ||| S:48 E:57 ||| JJ
extremity ||| S:57 E:66 ||| NN
:  ||| S:66 E:68 ||| :
epidemiological ||| S:68 E:83 ||| CD
,  ||| S:83 E:85 ||| ,
clinical  ||| S:85 E:94 ||| JJ
and  ||| S:94 E:98 ||| CC
histopathological  ||| S:98 E:116 ||| JJ
aspects  ||| S:116 E:124 ||| NNS
Malignant  ||| S:124 E:134 ||| JJ
tumors  ||| S:134 E:141 ||| NNS
represent  ||| S:141 E:151 ||| VBP
one  ||| S:151 E:155 ||| CD
of  ||| S:155 E:158 ||| IN
the  ||| S:158 E:162 ||| DT
most  ||| S:162 E:167 ||| RBS
important  ||| S:167 E:177 ||| JJ
medical  ||| S:177 E:185 ||| JJ
problems ||| S:185 E:193 ||| NNS
,  ||| S:193 E:195 ||| ,
due  ||| S:195 E:199 ||| JJ
to  ||| S:199 E:202 ||| TO
the  ||| S:202 E:206 ||| DT
increased  ||| S:206 E:216 ||| JJ
mortality  ||| S:216 E:226 ||| NN
rate ||| S:226 E:230 ||| NN
,  ||| S:230 E:232 ||| ,
life  ||| S:232 E:237 ||| NN
quality  ||| S:237 E:245 ||| NN
alteration ||| S:245 E:255 ||| NN
,  ||| S:255 E:257 ||| ,
and  ||| S:257 E:261 ||| CC
the  ||| S:261 E:265 ||| DT
lack  ||| S:265 E:270 ||| NN
of  ||| S:270 E:273 ||| IN
a  ||| S:273 E:275 ||| DT
curable  ||| S:275 E:283 ||| JJ
treatment ||| S:283 E:292 ||| NN
.  ||| S:292 E:294 ||| .
Skin  ||| S:294 E:299 ||| NN
neoplasm  ||| S:299 E:308 ||| NN
ranks  ||| S:308 E:314 ||| VBZ
first  ||| S:314 E:320 ||| JJ
most  ||| S:320 E:325 ||| RBS
frequent  ||| S:325 E:334 ||| JJ
top  ||| S:334 E:338 ||| JJ
primary  ||| S:338 E:346 ||| JJ
tumor ||| S:346 E:351 ||| NN
,  ||| S:351 E:353 ||| ,
summing  ||| S:353 E:361 ||| VBG
a  ||| S:361 E:363 ||| DT
higher  ||| S:363 E:370 ||| JJR
percentage  ||| S:370 E:381 ||| NN
than  ||| S:381 E:386 ||| IN
any  ||| S:386 E:390 ||| DT
other  ||| S:390 E:396 ||| JJ
neoplastic  ||| S:396 E:407 ||| JJ
location ||| S:407 E:415 ||| NN
.  ||| S:415 E:417 ||| .
It  ||| S:417 E:420 ||| PRP
is  ||| S:420 E:423 ||| VBZ
also  ||| S:423 E:428 ||| RB
known ||| S:428 E:433 ||| VBN
,  ||| S:433 E:435 ||| ,
the  ||| S:435 E:439 ||| DT
fact  ||| S:439 E:444 ||| NN
that ||| S:444 E:448 ||| IN
,  ||| S:448 E:450 ||| ,
in  ||| S:450 E:453 ||| IN
our  ||| S:453 E:457 ||| PRP$
country ||| S:457 E:464 ||| NN
,  ||| S:464 E:466 ||| ,
gastric  ||| S:466 E:474 ||| JJ
adenocarcinoma  ||| S:474 E:489 ||| NN
represents  ||| S:489 E:500 ||| VBZ
the  ||| S:500 E:504 ||| DT
most  ||| S:504 E:509 ||| RBS
encountered  ||| S:509 E:521 ||| JJ
tumor  ||| S:521 E:527 ||| NN
of  ||| S:527 E:530 ||| IN
the  ||| S:530 E:534 ||| DT
digestive  ||| S:534 E:544 ||| JJ
tube ||| S:544 E:548 ||| NN
.  ||| S:548 E:550 ||| .
Our  ||| S:550 E:554 ||| PRP$
case ||| S:554 E:558 ||| NN
,  ||| S:558 E:560 ||| ,
male ||| S:560 E:564 ||| NN
,  ||| S:564 E:566 ||| ,
49-year-old ||| S:566 E:577 ||| JJ
,  ||| S:577 E:579 ||| ,
comes  ||| S:579 E:585 ||| VBZ
from  ||| S:585 E:590 ||| IN
a  ||| S:590 E:592 ||| DT
rural  ||| S:592 E:598 ||| JJ
area ||| S:598 E:602 ||| NN
,  ||| S:602 E:604 ||| ,
was  ||| S:604 E:608 ||| VBD
diagnosed  ||| S:608 E:618 ||| VBN
with  ||| S:618 E:623 ||| IN
and  ||| S:623 E:627 ||| CC
surgically  ||| S:627 E:638 ||| RB
treated ||| S:638 E:645 ||| VBN
,  ||| S:645 E:647 ||| ,
within  ||| S:647 E:654 ||| IN
one  ||| S:654 E:658 ||| CD
year ||| S:658 E:662 ||| NN
,  ||| S:662 E:664 ||| ,
for  ||| S:664 E:668 ||| IN
gastric  ||| S:668 E:676 ||| JJ
adenocarcinoma  ||| S:676 E:691 ||| NNS
( ||| S:691 E:692 ||| -LRB-
intestinal  ||| S:692 E:703 ||| FW
type  ||| S:703 E:708 ||| FW
gastric  ||| S:708 E:716 ||| FW
carcinoma ||| S:716 E:725 ||| FW
)  ||| S:725 E:727 ||| -RRB-
and  ||| S:727 E:731 ||| CC
squamous  ||| S:731 E:740 ||| JJ
cell  ||| S:740 E:745 ||| NN
carcinoma  ||| S:745 E:755 ||| NNS
( ||| S:755 E:756 ||| -LRB-
at  ||| S:756 E:759 ||| IN
the  ||| S:759 E:763 ||| DT
level  ||| S:763 E:769 ||| NN
of  ||| S:769 E:772 ||| IN
the  ||| S:772 E:776 ||| DT
lower  ||| S:776 E:782 ||| JJR
lip ||| S:782 E:785 ||| NN
) ||| S:785 E:786 ||| -RRB-
.  ||| S:786 E:788 ||| .
A  ||| S:788 E:790 ||| DT
high  ||| S:790 E:795 ||| JJ
number  ||| S:795 E:802 ||| NN
of  ||| S:802 E:805 ||| IN
etiologic  ||| S:805 E:815 ||| JJ
agents  ||| S:815 E:822 ||| NNS
are  ||| S:822 E:826 ||| VBP
associated  ||| S:826 E:837 ||| VBN
with  ||| S:837 E:842 ||| IN
different  ||| S:842 E:852 ||| JJ
risks  ||| S:852 E:858 ||| NNS
in  ||| S:858 E:861 ||| IN
developing  ||| S:861 E:872 ||| VBG
a  ||| S:872 E:874 ||| DT
carcinoma  ||| S:874 E:884 ||| NN
with  ||| S:884 E:889 ||| IN
squamous  ||| S:889 E:898 ||| JJ
cells  ||| S:898 E:904 ||| NNS
at  ||| S:904 E:907 ||| IN
the  ||| S:907 E:911 ||| DT
level  ||| S:911 E:917 ||| NN
of  ||| S:917 E:920 ||| IN
the  ||| S:920 E:924 ||| DT
head  ||| S:924 E:929 ||| NN
and  ||| S:929 E:933 ||| CC
the  ||| S:933 E:937 ||| DT
neck ||| S:937 E:941 ||| NN
,  ||| S:941 E:943 ||| ,
and  ||| S:943 E:947 ||| CC
a  ||| S:947 E:949 ||| DT
gastric  ||| S:949 E:957 ||| JJ
carcinoma  ||| S:957 E:967 ||| NNS
( ||| S:967 E:968 ||| -LRB-
our  ||| S:968 E:972 ||| PRP$
patient  ||| S:972 E:980 ||| NN
is  ||| S:980 E:983 ||| VBZ
known  ||| S:983 E:989 ||| VBN
to  ||| S:989 E:992 ||| TO
suffer  ||| S:992 E:999 ||| VB
from  ||| S:999 E:1004 ||| IN
gastric  ||| S:1004 E:1012 ||| JJ
ulcer  ||| S:1012 E:1018 ||| NN
and  ||| S:1018 E:1022 ||| CC
Helicobacter  ||| S:1022 E:1035 ||| NNP
pylori ||| S:1035 E:1041 ||| NN
,  ||| S:1041 E:1043 ||| ,
for  ||| S:1043 E:1047 ||| IN
more  ||| S:1047 E:1052 ||| JJR
than  ||| S:1052 E:1057 ||| IN
20  ||| S:1057 E:1060 ||| CD
years ||| S:1060 E:1065 ||| NNS
,  ||| S:1065 E:1067 ||| ,
and  ||| S:1067 E:1071 ||| CC
he  ||| S:1071 E:1074 ||| PRP
is  ||| S:1074 E:1077 ||| VBZ
a  ||| S:1077 E:1079 ||| DT
chronic  ||| S:1079 E:1087 ||| JJ
consumer  ||| S:1087 E:1096 ||| NN
of  ||| S:1096 E:1099 ||| IN
alcohol  ||| S:1099 E:1107 ||| NN
and  ||| S:1107 E:1111 ||| CC
nicotine ||| S:1111 E:1119 ||| CD
) ||| S:1119 E:1120 ||| -RRB-
.  ||| S:1120 E:1122 ||| .
